126 related articles for article (PubMed ID: 22589484)
1. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy.
Loh ML; Mullighan CG
Clin Cancer Res; 2012 May; 18(10):2754-67. PubMed ID: 22589484
[TBL] [Abstract][Full Text] [Related]
2. [Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndromes].
Strullu M; Leblanc T; Lainey E
Bull Cancer; 2023 Nov; 110(11):1183-1195. PubMed ID: 37453833
[TBL] [Abstract][Full Text] [Related]
3. Clonal evolution and hierarchy in myeloid malignancies.
Takahashi K; Tanaka T
Trends Cancer; 2023 Sep; 9(9):707-715. PubMed ID: 37302922
[TBL] [Abstract][Full Text] [Related]
4. "Myeloid" Mutations in ALL Are Not Uncommon: Implications for Etiology and Therapies.
Iacobucci I
Blood Cancer Discov; 2024 May; 5(3):142-145. PubMed ID: 38689559
[TBL] [Abstract][Full Text] [Related]
5. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
Tasian SK; Loh ML; Hunger SP
Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies.
Tatwavedi D; Pellagatti A; Boultwood J
Adv Biol Regul; 2024 Jan; 91():100993. PubMed ID: 37827894
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in Myeloid Malignancies: From Bench to Bedside.
Soyfer EM; Fleischman AG
J Immunother Precis Oncol; 2021 Aug; 4(3):160-167. PubMed ID: 35663100
[TBL] [Abstract][Full Text] [Related]
8. Concepts in B-cell Acute Lymphoblastic Leukemia Pathogenesis.
Garcia C; Miller-Awe MD; Witkowski MT
J Leukoc Biol; 2024 Jan; ():. PubMed ID: 38243586
[TBL] [Abstract][Full Text] [Related]
9. Genetic Models of Leukemia in Zebrafish.
Baeten JT; de Jong JLO
Front Cell Dev Biol; 2018; 6():115. PubMed ID: 30294597
[TBL] [Abstract][Full Text] [Related]
10.
Niemeyer CM; Erlacher M
Haematologica; 2024 Apr; ():. PubMed ID: 38618667
[TBL] [Abstract][Full Text] [Related]
11. Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse.
Forero-Castro M; Montaño A; Robledo C; García de Coca A; Fuster JL; de Las Heras N; Queizán JA; Hernández-Sánchez M; Corchete-Sánchez LA; Martín-Izquierdo M; Ribera J; Ribera JM; Benito R; Hernández-Rivas JM
Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32635531
[TBL] [Abstract][Full Text] [Related]
12. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
[TBL] [Abstract][Full Text] [Related]
13. Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification.
Thakral D; Kaur G; Gupta R; Benard-Slagter A; Savola S; Kumar I; Anand R; Rani L; Verma P; Joshi S; Kumar L; Sharma A; Bakhshi S; Seth R; Singh V
Front Oncol; 2019; 9():871. PubMed ID: 31572674
[TBL] [Abstract][Full Text] [Related]
14. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.
Hashmi SK; Punia JN; Marcogliese AN; Gaikwad AS; Fisher KE; Roy A; Rao P; Lopez-Terrada DH; Ringrose J; Loh ML; Niemeyer CM; Rau RE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27905. PubMed ID: 31250550
[TBL] [Abstract][Full Text] [Related]
15. Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.
Chow M; Gao L; MacManiman JD; Bicocca VT; Chang BH; Alumkal JJ; Tyner JW
Oncogene; 2018 Sep; 37(38):5221-5232. PubMed ID: 29849118
[TBL] [Abstract][Full Text] [Related]
16. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.
Bhandari P; Ahmad F; Das BR
Med Oncol; 2017 May; 34(5):92. PubMed ID: 28401483
[TBL] [Abstract][Full Text] [Related]
18. [Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification].
Zhang L; Liu XM; Guo Y; Yang WY; Zhang JY; Liu F; Liu TF; Wang SC; Chen XJ; Ruan M; Qi BQ; Chang LX; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Jan; 18(1):34-8. PubMed ID: 26781410
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of childhood cancer: Biomarkers and novel therapies.
Saletta F; Wadham C; Ziegler DS; Marshall GM; Haber M; McCowage G; Norris MD; Byrne JA
BBA Clin; 2014 Jun; 1():59-77. PubMed ID: 26675306
[TBL] [Abstract][Full Text] [Related]
20. Can Peto's paradox be used as the null hypothesis to identify the role of evolution in natural resistance to cancer? A critical review.
Ducasse H; Ujvari B; Solary E; Vittecoq M; Arnal A; Bernex F; Pirot N; Misse D; Bonhomme F; Renaud F; Thomas F; Roche B
BMC Cancer; 2015 Oct; 15():792. PubMed ID: 26499116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
